Alzheimer’s: Nanotubes Shuttle Toxins in Brain Cells
Johns Hopkins researchers discovered nanotubes in brain cells that transport toxins, including amyloid-beta related to Alzheimer's. Controlling these nanotubes could offer a future treatment.
Microplastics, APOE4 Gene, and Alzheimer’s: Cognitive Decline Risk
Research links microplastic exposure to cognitive decline and Alzheimer's, especially in those with the APOE4 gene. Sex-dependent behavior changes observed in mice mirror human Alzheimer's patients.
Alzheimer’s Research: Therapies, Challenges & Future
Alzheimer's research is at a critical point with initial therapies emerging, but more efficient drugs are needed. Research focuses on early treatments, inflammation's role, and overcoming funding challenges. Biomarkers are vital.
Alzheimer’s: Cancer Drugs Show Promise in Reversing Brain Changes
Researchers identify cancer drugs (Letrozole, Irinotecan) that may reverse Alzheimer's brain changes by targeting gene expression. Combination therapy shows promise in mouse model, paving way for clinical trials.
Alzheimer’s: Insulin Resistance Flags Rapid Cognitive Decline
High insulin resistance (TyG index) may flag early Alzheimer's patients at 4x greater risk of rapid cognitive decline, offering new treatment possibilities. Metabolic stress is key.